Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$10.3M
+149.1% from 2023
Prescriptions
2,485
$4,130.68 per claim
Patients
766
461 prescribers
Total spending, 2024
$10.3M
$13,387.50 per patient
Medicare prescription drug plans paid $10.3M for Nyvepria in 2024, for 2,485 prescriptions and refills to 766 patients (up 149.1% from 2023). The average cost per claim was $4,130.68.
Michigan had the highest Medicare cost for Nyvepria in 2024: $1.9M for 473 claims, followed by New Jersey ($1.5M).
Sanjaykumar J Hapani, medical oncology in Edmond, OK, had the highest Medicare cost for Nyvepria in 2024: 121 claims costing $454K.
Nyvepria is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Sanjaykumar J Hapani Edmond, OK | Medical Oncology | 121 | 23 | $454K |
| Manish Dhawan Minden, LA | Hematology-Oncology | 51 | 16 | $231K |
| David J Tamura |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 81 | 268 | 98 | $1.2M |
| 2023 | 219 | 925 | 282 | $4.1M |
| 2024 | 461 | 2,485 | 766 | $10.3M |
Spending by manufacturer as listed in the spending data
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 39 |
| Under 11 |
| $174K |
| Andrew L Sochacki Grand Rapids, MI | Hematology-Oncology | 44 | 13 | $164K |
| Erin M Pettijohn Grand Rapids, MI | Hematology-Oncology | 42 | 13 | $152K |
| Kathrine A Cooper Reed City, MI | Hematology-Oncology | 36 | Under 11 | $139K |
| Zabila Saeed Norton Shores, MI | Hematology-Oncology | 22 | Under 11 | $135K |
| David P Ellent Kingwood, TX | Hematology-Oncology | 33 | Under 11 | $124K |
| Lori A Leslie Hackensack, NJ | Hematology-Oncology | 31 | Under 11 | $117K |
| Thomas E Gribbin Grand Rapids, MI | Hematology-Oncology | 32 | Under 11 | $117K |
| Sreenivasa Chandana Grand Rapids, MI | Hematology-Oncology | 23 | Under 11 | $115K |
| Tatyana A Feldman Hackensack, NJ | Hematology-Oncology | 29 | Under 11 | $109K |
| Eric D Batts Holland, MI | Hematology-Oncology | 27 | Under 11 | $108K |
| Mouhamad Bazzi Frederick, MD | Hematology-Oncology | 21 | Under 11 | $107K |
| Colin A Hardin Grand Rapids, MI | Medical Oncology | 25 | Under 11 | $104K |
| Saleha S Sajid Kingwood, TX | Hematology | 25 | Under 11 | $101K |
| Haritha G Reddy Grand Rapids, MI | Hematology-Oncology | 23 | Under 11 | $93K |
| Kelly J Parling-Lynch Norton Shores, MI | Hematology-Oncology | 25 | Under 11 | $91K |
| Trina Poretta Voorhees, NJ | Hematology-Oncology | 26 | Under 11 | $91K |
| Amy C Vander Woude Grand Rapids, MI | Hematology-Oncology | 23 | Under 11 | $88K |
| Beiqing Pan Bridgewater, NJ | Hematology-Oncology | 16 | Under 11 | $87K |
| Aaron T Bowman Reno, NV | Hematology-Oncology | 23 | Under 11 | $86K |
| Jerry J George Port Jefferson Station, NY | Hematology-Oncology | 11 | Under 11 | $83K |
| Hemalatha Vasireddy Belleville, NJ | Hematology-Oncology | 14 | Under 11 | $83K |
| Kathryn B Alguire Norton Shores, MI | Medical Oncology | 19 | Under 11 | $76K |
| Manufacturer | Claims | Spending |
|---|---|---|
| Pfizer US Pharm PFE | 2,486 | $10.3M |